adminBy Ben Glickman
Shares of BioVie rose Monday ahead of the company presenting trial data for its treatment for Alzheimer’s Disease.
The stock was up 12%, to $3.58, in afternoon trading, bouncing off a 52-week low last week. Shares have fallen 54% this year.
The…
Read the full article here
